Miah Hiang Tay

A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma

Ho Yeong Lim, Jeong Heo, Hye Jin Choi et al. · Clinical Cancer Research · 2014 · 99 citations · Full text

Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma

Swan‐Swan Leong, Joseph Wee, Miah Hiang Tay et al. · Cancer · 2004 · 80 citations · Full text

Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5‐fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinoma

Swan Swan Leong, Joseph Wee, Sandeep K. Rajan et al. · Cancer · 2008 · 66 citations

A Randomized Phase II Trial of Single-Agent Gemcitabine, Vinorelbine, or Docetaxel in Patients with Advanced Non-small Cell Lung Cancer Who Have Poor Performance Status and/or Are Elderly

Swan Swan Leong, Chee‐Keong Toh, Wan‐Teck Lim et al. · Journal of Thoracic Oncology · 2007 · 54 citations

Medicine, Single-agent Gemcitabine, Pharmacology +8

Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial

Cora N. Sternberg, Daniel Castellano, Gedske Daugaard et al. · The Lancet Oncology · 2014 · 53 citations

Urology, Abiraterone Acetate, Medicine +8